Substitutes for Mabtas 500 Infusion
Composition: Rituximab 500mg
Mabtas 500 Infusion is out of stock right now
Good news — 5 medicines with the same composition are listed below and can be ordered instead.
You're viewing
Mabtas 500 Infusion
RxIntas Pharmaceuticals Ltd
₹43404 Out of stock
View details Same molecule
5Same active ingredient(s) but a different strength or form — check the strength matches your prescription.
Rx Required
Ikgdar 100mg Injection
Cipla Ltd
Rituximab100mg
₹7609
Out of Stock Save ₹35795 (82% off)
Rx Required
Enfiera 100mg Injection
Zydus Lifesciences Ltd
Rituximab100mg
₹8532
Out of Stock Save ₹34872 (80% off)
About this molecule
Rituximab500mg
Full details →Rituximab is a monoclonal antibody used to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia. It works by targeting CD20 on B-cells, leading to their destruction. Rituximab is effective for managing hematological malignancies. In summary, it is a vital therapy for specific blood cancers.
Why a generic substitute?
Same active ingredient
A substitute has the exact same salt(s) — so it works the same way as the brand.
Often much cheaper
Generics can cost a fraction of the branded price for the identical molecule.
Quality-regulated
All medicines we list are from licensed sellers and meet the same standards.
Substitutes share the same active ingredients, but always confirm the strength and form with your doctor or pharmacist before switching — especially for chronic, prescription or narrow-therapeutic-index medicines.
